Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

Completed · Phase 2 · Has a placebo group

Conditions studied: Diabetes Mellitus, Non-Insulin-Dependent

In brief

Insulin is a chemical that the body needs in order to use or store sugar. It is made by a type of cell called a beta cell which resides in an organ known as the pancreas. Type 2 diabetes is a disease where the beta cells are unable to meet a person's insulin needs. Sugar levels rise in the blood as a result. INGAP-Peptide is being tested to attempt to create new beta cells in the pancreas, and to improve the ability to produce insulin in type 2 diabetic patients.

Key facts

Study ID

NCT00071422

Run by

Exsulin Corporation

People needed

126

Starts

2003-10-01

Expected to finish

2004-06-01

Last updated by the study team

2014-07-11

Who can join

Age: 35 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 35-70
• Using >20 Units of insulin per day
• HbA1c from 6.5% to 10%
• No islet antibodies
• Otherwise healthy

Where it is running

• Diabetes and Endocrine Associates — La Jolla, California, United States
• VA Hospital UCSD — San Diego, California, United States
• Diablo Clinical Research — Walnut Creek, California, United States
• Study site — Denver, Colorado, United States
• Longmont Medical Research Network — Longmont, Colorado, United States
• MedStar Clinical Research Center — Washington D.C., District of Columbia, United States
• Future Care Studies — Springfield, Massachusetts, United States
• Mercury Street Medical — Butte, Montana, United States
• Diabetes-Endocrinology Center of WNY — Buffalo, New York, United States
• UNC Diabetes Care Center — Durham, North Carolina, United States
• Piedmont Medical Group — Winston-Salem, North Carolina, United States
• Clinical Research Institute of Southern Oregon — Medford, Oregon, United States
• Mountain View Clinical Research — Greer, South Carolina, United States
• Dallas Diabetes and Endocrine Center — Dallas, Texas, United States
• University of Texas Health Science Center - Texas Diabetes Institute — San Antonio, Texas, United States
• DGD Research Associates — San Antonio, Texas, United States
• Charlottesville Medical Research — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.